ADDITION OF LEADING SUPPLIERS BOLSTERS PRECISION’S BIOMARKER SERVICE OFFERINGS– BRINGING UNPARALLELED SCIENCE, SCALE, AND SERVICE TO THE BIOSPECIMEN INDUSTRY BETHESDA, MD – August 1, 2019 – Precision for Medicine, part of Precision Medicine Group, announced it has acquired leading biospecimen providers ProMedDx and GLAS, significantly expanding its capabilities and expertise […]

HOUSTON, TX – May 14, 2019 — Precision for Medicine, a Precision Medicine Group company, announced that it will provide its state-of-the-art laboratory services to perform drug assessment as part of a new personalized clinical trial designed to identify the most effective therapies for individual lymphoma patients at […]

The definition of personalized medicine has expanded beyond tailored medical treatment to encompass drug development, care delivery and consumer engagement—while precision medicine refers to the tailoring of medical treatment to the characteristics of a patient subpopulation. This PharmaVoice cover story explores the distinctions, the challenges and the implications, including insights […]